Histogen Inc - ESG Rating & Company Profile powered by AI
Complete Sustainability analysis of Histogen Inc can be accessed by signing up for free. The SDG score for Histogen Inc indicates the company's transparency towards the UN Sustainable Development Goals. If you are employed by Histogen Inc and you wish to licence your Sustainability rating, please get in touch.
Histogen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 2.7 and governance score of 8.0.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 744 | Sopharma AD | 5.0 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 764 | Histogen Inc | 4.9 | High |
| 764 | BetterLife Pharma Inc | 4.9 | High |
| 764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Histogen Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Histogen Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Histogen Inc report the average age of the workforce?
Sign up for free to unlockDoes Histogen Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Histogen Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Histogen Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Histogen Inc offer flexible work?
Sign up for free to unlockDoes Histogen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Histogen Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Histogen Inc conduct supply chain audits?
Sign up for free to unlockDoes Histogen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Histogen Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Histogen Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Histogen Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Histogen Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Histogen Inc disclose water use targets?
Sign up for free to unlockDoes Histogen Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Histogen Inc have a product recall in the last two years?
Sign up for free to unlockDoes Histogen Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Histogen Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Histogen Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Histogen Inc disclose parental leave metrics?
Sign up for free to unlockDoes Histogen Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Histogen Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Histogen Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Histogen Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Histogen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Histogen Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Histogen Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Histogen Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Histogen Inc disclose its waste policy?
Sign up for free to unlockDoes Histogen Inc report according to TCFD requirements?
Sign up for free to unlockDoes Histogen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Histogen Inc disclose energy use targets?
Sign up for free to unlockDoes Histogen Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Histogen Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Histogen Inc
These potential risks are based on the size, segment and geographies of the company.
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.